Elevance Health (ELV) Shares Outstanding (2009 - 2026)

Elevance Health (ELV) has 18 years of Shares Outstanding (Entity) data on file, last reported at $216.8 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 3.56% year-over-year to $216.8 million in Q2 2026; TTM through Jun 2026 was $216.8 million, a 3.56% decrease from a year earlier, with the FY2025 full-year figure at $220.7 million, down 2.97% from the prior year.
• Shares Outstanding (Entity) for Q2 2026 stood at $216.8 million, roughly flat from $217.4 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ELV reached as high as $241.1 million in Q1 2022 and fell as low as $216.8 million in Q2 2026.
• Historically, Shares Outstanding (Entity) has averaged $230.6 million across 5 years, with a median of $232.2 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) declined 1.27% in 2024 and dropped 4.27% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $238.0 million in 2022, then declined by 2.05% to $233.1 million in 2023, then declined by 2.4% to $227.5 million in 2024, then retreated by 2.97% to $220.7 million in 2025, then slipped by 1.76% to $216.8 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $216.8 million in Q2 2026, $217.4 million in Q1 2026, and $220.7 million in Q4 2025.